Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Acular

Generic name: Ketorolac tromethamine

FDA application holder: Abbvie

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Acular?
Acular is a brand name of Ketorolac tromethamine, a prescription medicine. The FDA NDC Directory lists 1 Acular product in 1 strength and form.
Who makes Acular?
Abbvie holds the FDA application for Acular (NDA019700, approved November 9, 1992).
Is there a generic or store brand of Acular?
Yes. The FDA NDC Directory lists 14 other products with the same active ingredients, strength and form as a Acular product, 14 of them generic. Ask your pharmacist whether one is right for you.
Has Acular been recalled?
No recall linked to Acular products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Acular is

Each Acular product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Ketorolac tromethamine · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
ketorolac tromethamine 5 mg/mL
solution/ drops (ophthalmic)
Acular 14 products, 8 companies DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Ketorolac tromethamine →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Acular products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA019700AbbvieNovember 9, 19921

Companies that list Acular

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Acular products.

Recalls

No recall linked to Acular products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers